Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2009

01-12-2009 | Article

Hemolytic uremic syndrome (HUS)—incidence and etiologies at a regional Children’s Hospital in 2001–2006

Authors: R. J. Pomajzl, M. Varman, A. Holst, A. Chen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2009

Login to get access

Abstract

Hemolytic uremic syndrome (HUS) is a serious health concern in children. HUS has primarily been linked to Escherichia coli O157:H7 infections, but non-O157 strains are gaining attention. Hemolytic anemia, thrombocytopenia, and acute renal failure are the characteristics of the syndrome. This study investigated the incidence of HUS at a regional Children’s Hospital between 2001 and 2006 by retrospective review. Cases of HUS were investigated for outcomes based on stool culture and an association of acute pancreatitis. A total of 44 cases were identified, of which 57% were female and 43% were male, with an age distribution of 13 months to 17 years and a median age of 3.44 years. Data revealed 13 cases in 2006 compared to two cases in 2001, with 84% of all illnesses occurring in the summer and fall seasons. The median duration of thrombocytopenia was eight days and 50% of all cases required dialysis. E. coli O157:H7 was the predominant pathogen; however, 53% of the cases had unknown etiology. This data may suggest a growing number of cases from 2001 to 2006 and a role for agents other than E. coli O157:H7. E. coli O157:H7 caused longer intensive care unit (ICU) stay. No association between HUS and acute pancreatitis was found.
Literature
1.
go back to reference Banatvala N, Griffin PM, Greene KD et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed Banatvala N, Griffin PM, Greene KD et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed
2.
go back to reference Friedrich AW, Zhang W, Bielaszewska M et al (2007) Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45:39–45CrossRefPubMed Friedrich AW, Zhang W, Bielaszewska M et al (2007) Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45:39–45CrossRefPubMed
3.
go back to reference Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74:991–996PubMed Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74:991–996PubMed
4.
go back to reference Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364–368CrossRefPubMed Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364–368CrossRefPubMed
5.
go back to reference Geelen JM, van der Velden TJ, van den Heuvel LP et al (2007) Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 22:1181–1187CrossRefPubMed Geelen JM, van der Velden TJ, van den Heuvel LP et al (2007) Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 22:1181–1187CrossRefPubMed
6.
go back to reference Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed
7.
go back to reference Chaisri U, Nagata M, Kurazono H et al (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31:59–67CrossRefPubMed Chaisri U, Nagata M, Kurazono H et al (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31:59–67CrossRefPubMed
8.
go back to reference Wickham ME, Lupp C, Mascarenhas M et al (2006) Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194:819–827CrossRefPubMed Wickham ME, Lupp C, Mascarenhas M et al (2006) Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194:819–827CrossRefPubMed
9.
go back to reference Brooks JT, Sowers EG, Wells JG et al (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192:1422–1429CrossRefPubMed Brooks JT, Sowers EG, Wells JG et al (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192:1422–1429CrossRefPubMed
10.
go back to reference Johnson KE, Thorpe CM, Sears CL (2006) The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43:1587–1595CrossRefPubMed Johnson KE, Thorpe CM, Sears CL (2006) The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43:1587–1595CrossRefPubMed
11.
go back to reference Mead PS, Slutsker L, Dietz V et al (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607–625CrossRefPubMed Mead PS, Slutsker L, Dietz V et al (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607–625CrossRefPubMed
12.
go back to reference Sass DA, Chopra KB, Regueiro MD (2003) Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome. Dig Dis Sci 48:415–416CrossRefPubMed Sass DA, Chopra KB, Regueiro MD (2003) Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome. Dig Dis Sci 48:415–416CrossRefPubMed
13.
go back to reference Brandt JR, Joseph MW, Fouser LS et al (1998) Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12:222–225CrossRefPubMed Brandt JR, Joseph MW, Fouser LS et al (1998) Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12:222–225CrossRefPubMed
14.
go back to reference Grodinsky S, Telmesani A, Robson WL et al (1990) Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 11:518–524PubMedCrossRef Grodinsky S, Telmesani A, Robson WL et al (1990) Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 11:518–524PubMedCrossRef
15.
go back to reference Centers for Disease Control and Prevention (CDC) (2006) Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach—United States, September 2006. MMWR Morb Mortal Wkly Rep 55:1045–1046 Centers for Disease Control and Prevention (CDC) (2006) Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach—United States, September 2006. MMWR Morb Mortal Wkly Rep 55:1045–1046
16.
go back to reference Joishy M, Jauhari P, Mathew AA et al (2008) Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection? Arch Dis Child 93:180–181CrossRefPubMed Joishy M, Jauhari P, Mathew AA et al (2008) Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection? Arch Dis Child 93:180–181CrossRefPubMed
17.
go back to reference Kandula L, Lowe ME (2008) Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 152:106–110CrossRefPubMed Kandula L, Lowe ME (2008) Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 152:106–110CrossRefPubMed
18.
go back to reference Hogan MC, Gloor JM, Uhl JR et al (2001) Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis 38:E22CrossRefPubMed Hogan MC, Gloor JM, Uhl JR et al (2001) Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis 38:E22CrossRefPubMed
19.
go back to reference Waters AM, Kerecuk L, Luk D et al (2007) Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 151:140–144CrossRefPubMed Waters AM, Kerecuk L, Luk D et al (2007) Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 151:140–144CrossRefPubMed
20.
go back to reference Oakes RS, Siegler RL, McReynolds MA et al (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117:1656–1662CrossRefPubMed Oakes RS, Siegler RL, McReynolds MA et al (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117:1656–1662CrossRefPubMed
21.
go back to reference Ahmed A, Li J, Shiloach Y et al (2006) Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2–5-year-old children. J Infect Dis 193:515–521CrossRefPubMed Ahmed A, Li J, Shiloach Y et al (2006) Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2–5-year-old children. J Infect Dis 193:515–521CrossRefPubMed
22.
go back to reference Fey PD, Wickert RS, Rupp ME et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533CrossRefPubMed Fey PD, Wickert RS, Rupp ME et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533CrossRefPubMed
Metadata
Title
Hemolytic uremic syndrome (HUS)—incidence and etiologies at a regional Children’s Hospital in 2001–2006
Authors
R. J. Pomajzl
M. Varman
A. Holst
A. Chen
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0800-y

Other articles of this Issue 12/2009

European Journal of Clinical Microbiology & Infectious Diseases 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.